Clinical trial
High On-treatment Platelet Reactivity to Adenosine Diphosphate Identified by Multiple Platelet Function Assay Guide to Modify Anti-platelet Strategy in Patients Undergoing Percutaneous Coronary Intervention
NCT02699008 is registered in ClinicalTrials.gov with Wuhan Asia Heart Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- High On-treatment Platelet Reactivity to Adenosine Diphosphate Identified by Multiple Platelet Function Assay Guide to Modify Anti-platelet Strategy in Patients Undergoing Percutaneous Coronary Intervention
- Lead sponsor
- Wuhan Asia Heart Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2014
- Completion date
- October 31, 2015
- Enrollment
- 477 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.